Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Figure out How to Track and Anticipate Future Cd Rates - 2Best Streaming Gadget for Your Home Theater
- 37 Peculiar Ways Of starting Your Imagination: Motivation Has Never Been This Good times
- 4Vote In favor of Your Favored Kind Of Vegetable
- 5Dolly Parton misses Dollywood event due to 'a few health challenges' after skipping honorary Oscars
- What to know about Jack Dorsey's new Vine revival, DiVine
- 7 Odd Apparatuses to Make Your Party Stick Out!
- British-Egyptian dissident apologises for tweets as Tories push for UK deportation
- 4 Dazzling And Well known Island Objections In US
- Michael Jordan donates $10M to North Carolina medical center in honor of his mother
- Analysis-From 'Icarus bug' to flawed panels: Airbus counts cost of relying on single model
- How do my eyes adjust to the dark and how long does it take?
- Nitty gritty Manual for Picking Agreeable Tennis shoes
- Medicine doesn’t just have ‘conscientious objectors’ − there are ‘conscientious providers,’ too
